Clinical trial
Placebo-controlled Comparative Study of NPC-12Y Gel in Patients With Skin Lesions Associated With Tuberous Sclerosis Complex
NCT05495425 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Placebo-controlled Comparative Study of NPC-12Y Gel in Patients With Skin Lesions Associated With Tuberous Sclerosis Complex
- Lead sponsor
- Nobelpharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- October 30, 2024
- Enrollment
- 43 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
tuberous sclerosis complex